Ophthalmology
Established Site Network, Rapid
Start-Up, Reliable Outcomes
REV Clinical brings unmatched depth in ophthalmology trials, combining trusted site relationships, strong KOL networks, and seamless execution leveraging our Global Velocity Network™. Our team accelerates feasibility, streamlines start-up, and ensures data integrity, delivering reliable outcomes across early- and mid-phase ophthalmology studies.
Ophthalmology Clinical
Study Capabilities
REV Clinical executes ophthalmology studies end-to-end, from first-in-human to pivotal and post-market, with adaptive design, rigorous oversight, and multi-region operations that accelerate enrollment, uphold quality, and streamline submissions.
- FIH, Phase I & II studies
- Dose escalation studies (SAD/MAD)
- PK/PD interaction studies
- Biosimilar studies
- Phase III and Phase IV studies
- PMS studies
- Patient registry trials
- Concept designing, regulatory strategy drafting & FDA communications
- Confirmatory phase III studies
- Clinical endpoint studies
- Pilot studies
- Pivotal studies
- Premarket Approval (PMA) trials
- 510K studies
- Human factor studies
- Significant risk (SR) studies
- Non-significant risk (NSR) studies
Wide Breadth of
Ophthalmology
Indications
REV has experience with both anterior and posterior ophthalmology trials for therapeutics and medical devices. This extensive experience gives our sponsors the flexibility to work with REV across a wide range of ophthalmology trial types.
- Blepharitis
- Keratitis
- Pterygium
- Pinguecula
- Chalazion
- wAMD (Wet AMD)
- DME (Diabetic Macular Edema)
- GA (Geographic Atrophy)
- Diabetic Retinopathy
- Macular Degeneration
- Macular Edema
- Retinal Artery Occlusion
- Retinal Vein Occlusion
- Uveitis (Posterior)
- Mutation-Related Conditions
- Dry Eye
- Presbyopia
- Myopia
- Astigmatism
- Conjunctivitis
- Pterygium
- Cataracts
- Glaucoma (Open-Angle)
- Corneal Ulcer
Established
KOL and Site
Relationships
We have had long-standing relationships with ophthalmology investigators and key opinion leaders across all major subspecialties. This network enables rapid site identification, strong engagement of physician investigators (PIs), and feasibility guided by trusted experts.
Operational Ease
REV’s ophthalmology team has leveraged its leadership team and KOL network to establish a robust approach to ophthalmology clinical trial execution. Sites know REV well, and we know the right investigators, streamlining feasibility, start-up, and execution.
Global Reach
REV fully leverages its U.S., India, and Australia operations for ophthalmology programs, enabling sponsors to conduct credible global or regional trials quickly and cost-effectively.
Global Velocity Network Facilitates Strategic Market Access for Ophthalmology Trials
Pre-Study Rigor Delivers Faster Starts & Fewer Change Orders for Ophthalmology Trials
Expert Ophthalmology Biostatistics & Clinical Data Management
Ophthalmology Study
Start-Up Services
Perhaps you are waiting for regulatory approvals, additional funding, or the completion of intellectual property filings. REV’s oncology study start-up services can be offered as a standalone service, separate from the operational plan, so that you’ll be positioned to rapidly secure your first patient when you are ready.
01
02
03
04
Regulatory, Quality & Compliance Excellence
REV Clinical’s dedication to excellence is grounded in rigorous process governance, compliance, and an understanding of the regulatory frameworks of the world’s leading regulators.
Let’s Move Your Study Forward
Interested in connecting with REV Clinical’s team of interdisciplinary experts to answer questions, take action on your RFP, and clearly define next steps?